Tritec Articles
Pylorid Vs Omeprazole For HP Eradication
19 May 1997
Glaxo Wellcome 1996 Product Performance
17 March 1997
Glaxo Granted Rights To P&G Ulcer Drug
2 December 1996
P&G To Launch Low-Cost Helicobacter Regimen In USA
2 September 1996
Glaxo Wellcome's Tritec Cleared In USA
19 August 1996
Ulcer Therapy Market Set For Transformation
18 December 1995
Glaxo Wellcome Unveils Revamped Pipeline
20 November 1995
Glaxo Wellcome Revamps R&D To Treble Productivity
13 November 1995
Glaxo Wellcome's Pylorid Launched In First Market
18 September 1995
First Approval For GW's Ranitidine Bismuth Citrate
24 July 1995
Glaxo Interim Profits Up 10% On 2% Sales Rise
13 February 1995
Glaxo Files For Ranitidine Bismuth Citrate Approval
2 January 1995
Glaxo's Pipeline Update As Expected
19 September 1994
Competition and Acquisition Pressure Hits Glaxo
19 September 1994
FIRST CLINICAL DATA FOR GLAXO'S GR122311X
6 June 1994
GLAXO REAFFIRMS COMMITMENT TO R&D
6 December 1993
Showing 1-17 of 17 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
